Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Andy Schectman: BRICS, Trump and Gold — What Will Wake the Public Up?

by admin February 6, 2025
February 6, 2025
Andy Schectman: BRICS, Trump and Gold — What Will Wake the Public Up?

Andy Schectman, president of Miles Franklin, outlined his latest thoughts on the BRICS nations, sharing his thoughts on whether the bloc’s plans will be affected by Donald Trump’s return.

‘So no, this will not stop their drive to accumulate gold and to lessen their dependence on the dollar.’

Schectman also noted that gold and silver are still underowned in the US, and explained what could trigger more buying. In his view, it could take an event as significant as a major bank bail-in.

Watch the interview above for more on what Schectman sees coming in 2025, as well as how to position. You can also click here to view our Vancouver Resource Investment Conference playlist on YouTube.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
Lynette Zang: A Battle Royale is Coming, Sound Money is Safety
next post
Updated Commercial Development Plan for North America’s First Lithium Brine Production Facility

Related Posts

Skyharbour’s Partner North Shore Uranium Signs Exploration Agreement...

March 21, 2025

Subscriptions Reach 13K in Two Months

April 2, 2025

Tech 5: Major Players Release Latest Results, Google’s...

April 27, 2025

Cobalt Market Update: Q1 2025 in Review

April 10, 2025

Nuvau Minerals Inc. to Participate in BMO and...

February 22, 2025

Joe Cavatoni: Gold Shining, Risk Assets Under Pressure...

March 28, 2025

Orano Condemns Illegal Uranium Transfer from Niger Mine

November 29, 2025

Uranium Price Forecast: Top Trends for Uranium in...

December 15, 2025

Crypto Market Recap: Bitcoin Price Stalls as Fed...

June 21, 2025

5 US Longevity and Anti-aging Stocks to Watch...

January 24, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved